Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Blood|September 26, 2008
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemiaSophia Adamia, Amanda A Reichert, Hemalatha Kuppusamy, et al.Blood|January 29, 2005
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patientsJonathan J Keats, Christopher A Maxwell, Brian J Taylor, et al.Leukemia Research|August 6, 2011
Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myelomaRobert P Evans, Greg Dueck, Roger Sidhu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studiesJennifer A Woyach, Amy S Ruppert, Kanti Rai, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applicationsSteven P Treon, Linda M Pilarski, Andrew R Belch, et al.Immunology and Cell Biology|March 18, 2017
MS4A4A: a novel cell surface marker for M2 macrophages and plasma cellsRatna Sanyal, Maria J Polyak, Jonathan Zuccolo, et al.American Journal of Hematology|March 2, 2021
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trialChristopher P Venner, Richard LeBlanc, Irwindeep Sandhu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphomaRonald Levy, Kristen N Ganjoo, John P Leonard, et al.The New England Journal of Medicine|September 4, 2014
Lenalidomide and dexamethasone in transplant-ineligible patients with myelomaLotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, et al.Pageof 6